lung cancer

2023 ASCO Annual Meeting; #ASCO23
June 4, 2023 · ASCO Staff
The ASCO Annual Meeting is being held June 2 to 6. Several notable studies will be presented today. Topics include radiation therapy in rectal cancer, osimertinib for lung cancer, vorasidenib for grade 2 glioma, nivolumab for Hodgkin lymphoma, and mirvetuximab soravtansine for ovarian cancer. Read More >>
ASCO ® Plenary Series
April 19, 2023 · Greg Guthrie, ASCO staff
Read about 2 studies from the April 2023 ASCO Plenary Series, which highlights the use of adagrasib to target several solid tumors with a KRAS G12C mutation and the use of toripalimab to treat stage III non-small cell lung cancer before and after surgery. Read More >>
ASCO ® Plenary Series
December 19, 2022 · Greg Guthrie, ASCO staff
Read research from the December 2022 session of the ASCO Plenary Series, which explores combining immunotherapy for advanced non-small cell lung cancer with high PD-L1. Read More >>
December 15, 2022 · Sarah Saulsberry, PT, COMT
Physical therapist Sarah Saulsberry, PT, COMT, shares how prehabilitation can help people with lung cancer prepare for surgery, how it can help during recovery, and 4 exercises to get started with prehabilitation at home. Read More >>
December 1, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, Dr. Xiuning Le discusses research from the 2022 North America Conference on Lung Cancer, including 3 studies evaluating targeted therapy treatments for people with non-small cell lung cancer. Read More >>